◀ Back to SOD3
APOB — SOD3
Text-mined interactions from Literome
Laukkanen et al., Gene 2000
:
It was found that recombinant
EC-SOD reduced both the degradation of
LDL in RAW 264 macrophages by 28-36 % and its electrophoretic mobility caused by endothelial cell mediated oxidation
Yamamoto et al., Atherosclerosis 2002
(Arteriosclerosis) :
Very recently, it has been reported that exogenous addition of
EC-SOD or overexpression of EC-SOD
prevented endothelial cell mediated oxidative modification of
LDL
Zhao et al., Atherosclerosis 2005
(Arteriosclerosis) :
Gly-LDL caused less increases in
SOD , GPx or catalase activity, but more evident changes in GR activity and H ( 2 ) O ( 2 ) release compared to oxLDL or LDL
Wang et al., J Appl Physiol 2006
:
This experiment obtained the following findings : 1 )
ox-LDL increased monocyte ROS production and was accompanied by decreased c-SOD and m-SOD activities, as well as t-GSH and r-GSH contents, whereas treating monocytes with diphenyleneiodonium ( DPI ) ( a NADPH oxidase inhibitor ) or rotenone/2-thenoyltrifluoroacetone ( TTFA ) ( mitochondrial complex I/II inhibitors ) hindered ox-LDL induced monocyte ROS production ; 2 ) production of ROS and reduction of
m-SOD activity and r-GSH content in monocyte by ox-LDL were enhanced by heavy exercise and depressed by mild and moderate exercise ; and 3 ) heavy exercise augmented the inhibition of ox-LDL induced monocyte ROS production by DPI and rotenone/TTFA, whereas these DPI- and rotenone/TTFA mediated monocyte ROS productions were unchanged in response to mild and moderate exercise
Bao et al., J Cardiovasc Pharmacol 2006
:
Besides, it was observed that
ox-LDL triggered superoxide production and
suppressed the
superoxide dismutase activity, both of which could be prevented by FSBT pretreatment
Uchiyama et al., J Biol Chem 2006
(Hepatitis) :
CuZn-SOD deficiency
causes ApoB degradation and induces hepatic lipid accumulation by impaired lipoprotein secretion in mice
Verreth et al., Br J Pharmacol 2007
(Atherosclerosis...) :
Rosuvastatin restores
superoxide dismutase expression and
inhibits accumulation of oxidized
LDL in the aortic arch of obese dyslipidemic mice
Rankin et al., J Lipid Res 1991
:
SOD had a greater inhibitory effect on the modification of
LDL by U937 cells and fibroblasts ( 32 % and 64 %, respectively ) but again LO inhibitors had a much greater effect ( 79 to 100 % inhibition )
Kumar et al., Indian J Biochem Biophys 2010
(Diabetes Mellitus, Experimental) :
The decrease of lipids and apoprotein levels of VLDL and
LDL were
followed by stimulation of plasma post-heparin lipolytic activity and lecithin cholesterol acyltransferase as well as hepatic
superoxide dismutase and catalase activities
McNally et al., J Immunol 1990
:
In this study, the requirement for lipoxygenase activity is shown, in that 1 ) inhibitors of lipoxygenase prevent the alteration of LDL, 2 ) copper ( II ) ( 3,5-diisopropylsalicylic acid ), an agent shown to enhance lipoxygenase activity in a cell-free system, similarly enhances monocyte mediated LDL alteration, and 3 ) the ( 3,5-diisopropylsalicylic acid ) -enhanced monocyte mediated modification of
LDL can be completely
blocked by inhibitors of lipoxygenase or by
superoxide dismutase
Xu et al., Wei Sheng Yan Jiu 2011
(Hyperlipidemias) :
In comparison with high fat diet model group, serum TC, TG,
LDL-C and MDA were decreased but HDL-C and
SOD were
increased in lycopene groups
Kinscherf et al., FASEB J 1997
(Arteriosclerosis...) :
Induction of mitochondrial manganese
superoxide dismutase in macrophages by oxidized
LDL : its relevance in atherosclerosis of humans and heritable hyperlipidemic rabbits